EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers ( ally in an AML cell line. MKC-1theref...)

EntreMed Presents Preclinical Data for MKC-1 in Hematological,Cancers

ally in an AML cell line. MKC-1, therefore, induces apoptosis in hematopoietic cell lines and patient samples through a complex mechanism involving arrest of the cell cycle and disruption of multiple oncogenic survival pathways.

Mark R. Bray, Ph.D., EntreMed's Vice President Research, commented on the results, "These data provide further evidence that MKC-1 disrupts multiple survival pathways in tumor cells, including the PI3-Kinase and mTOR signaling pathways. Our results indicate that MKC-1 causes cell cycle arrest and induces apoptosis both in leukemia cell lines and in leukemia patient samples."

Dr. Bray also commented, "These findings further support our plans to evaluate MKC-1 in leukemia patients, either as a single agent or in combination with other chemotherapeutic agents. MKC-1 is currently in Phase 2 trials for metastatic breast cancer and non-small cell lung cancer, as well as a Phase 1 clinical trial for leukemia. We plan to continue evaluating the clinical potential for MKC-1 in both solid and hematological tumors."

To view the poster presentation, visit Scientific Presentations under the Therapeutic Pathways section of the Company's web site at www.entremed.com.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. Panzem(R) (2-methoxyestradiol or 2ME2), the Company's lead drug candidate, is currently in Phase 2 clinical trials for cancer, as well as in preclinical development for rheumatoid arthritis. MKC-1, an oral cell cycle regulator, is in Phase 2 studies for cancer. ENMD-1198, a novel tubulin binding agent, is also in Phase 1 studies in advanced cancers. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell cycle regulation and inflammation -- processes vital to the treatment of cancer a
'"/>

Page: 1 2 3 4
Related medicine technology :

1. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
2. Phase 2 Results for EntreMeds Panzem NCD Brain Cancer Study Presented at ASCO
3. EntreMeds Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models
4. EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting
5. EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models
6. EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
9. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
10. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
11. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis

Post Your Comments:

(Date:5/17/2013)... , May 17, 2013 Boehringer Ingelheim will ... disease at the American Thoracic Society International Conference ... , May 17 – 22. Data ... for the treatment of chronic obstructive pulmonary disease ... well as investigational compounds for asthma, idiopathic pulmonary ...

(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will ... March 31, 2013, before market on Tuesday, May 28, 2013. ... 28, 2013, at 8:00 a.m. EDT (May 28, 2013 at ... results and provide an update on recent corporate developments. ...

(Date:5/16/2013)... Nektar Therapeutics, (Nasdaq: NKTR ) President and ... is scheduled to present at the upcoming 2013 UBS Global ... the Sheraton New York Hotel on Tuesday, May 21, 2013 ... be accessible via a Webcast through a link posted in ... http://www.nektar.com . This Webcast will be available for replay ...

Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8 Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2 Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3 Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2

[0] Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference [0] Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results [0] Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City

... ,, NEW YORK , Aug. 2 Reportlinker.com announces that a new ... , , ... , , ... This research service ...

... July 31 , Massachusetts lawmakers passed legislation that includes limited ... , , ... mandatory minimum sentences at county Houses of Correction will have greater access ... on did not include two reforms previously endorsed by the Senate: allowing ...

Cached Medicine Technology:Western European Market for Image-guided and Robot-assisted Surgery 2 Western European Market for Image-guided and Robot-assisted Surgery 3 Western European Market for Image-guided and Robot-assisted Surgery 4 Western European Market for Image-guided and Robot-assisted Surgery 5 Western European Market for Image-guided and Robot-assisted Surgery 6 Western European Market for Image-guided and Robot-assisted Surgery 7 Western European Market for Image-guided and Robot-assisted Surgery 8 FAMM Applauds Massachusetts Legislature for Sentencing Reforms 2

Western European Market for Image-guided and Robot-assisted Surgery FAMM Applauds Massachusetts Legislature for Sentencing Reforms

(Date:5/18/2013)... few extra cups of coffee each month might help ... as primary sclerosing cholangitis (PSC), a new study suggests. ... found that drinking coffee was associated with a reduced ... cirrhosis of the liver, liver failure and biliary cancer. ... "While rare, PSC has extremely detrimental effects," ...

(Date:5/18/2013)... Orlando, FL (May 18, 2013) There are ... procedures commonly used to diagnose or treat gastrointestinal ... Week (DDW). , A study by New ... that more objective testing may substantially reduce the ... (GERD). Although GERD is believed to affect nearly ...

(Date:5/18/2013)... Assisted living and retirement communities have ... comfort of their residents. Systems Technologies is well-acquainted ... effective and cost-efficient solution – VisionLink Wireless Nurse ... communications solution that helps nurses provide the highest ... privacy. , The VisionLink nurse call ...

(Date:5/18/2013)... New York (PRWEB) May 18, 2013 ... pelvic mesh products continue to move forward in a ... Court, Bernstein Liebhard LLP reports. According to a notice ... in the Ethicon pelvic mesh litigation will be held ... 2,755 complaints have been filed in the proceeding on ...

(Date:5/18/2013)... 2013 The “World Healthcare IT Market: ... the major market drivers, restraints, and opportunities in North ... Browse , 89 market data ... on "Healthcare IT Market" , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html ... reports. , The global healthcare IT market is expected ...

Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2 Health News:New research identifies practice changes to improve value and quality of GI procedures 2 Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2 Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3 Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2 Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3 Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2 Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3

[0] Study Links Coffee to Lower Risk for Rare Liver Disease [0] New research identifies practice changes to improve value and quality of GI procedures [0] VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities [0] Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation [0] Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets

... of phosphate in the blood are more likely to ... key indicator of atherosclerosis and future cardiovascular disease risk, ... the Journal of the American Society of Nephrology ... unidentified and modifiable cardiovascular risk factor, and could help ...

... Diluted Share, FARMINGDALE, N.Y., Nov. 13 Misonix, ... ultrasonic medical device,technology, which in Europe is used for ... conditions, today reported financial,results for its fiscal year 2009 ... President and Chief Executive Officer, and Richard,Zaremba, Senior VP ...

... Savings Over 70% Are Easily Found with Free, ... 13 With one-quarter of,Americans paying out-of-pocket to ... in coming months, PharmacyChecker.com published "Safe,Strategies for Drug ... By,shopping online at verified pharmacies in the U.S., ...

... S.C., Nov. 13 Companion Benefit,Alternatives Inc. ... and substance,abuse treatment benefits in South Carolina, ... among 23 finalists in URAC,s prestigious,Best Practices ... Awards,competition., URAC, a leading independent accrediting ...

... more stringent standards that require nurses to submit fingerprints and undergo ... years. RecordGone.com helps nurses expunge their criminal records, making it ... , ... Costa Mesa, CA (PRWEB) November 13, 2008 ...

... gender, race and/or marital status can factor into the ... gender is the most significant factor impacting overall survival, ... Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, ... National Cancer Institute, in 2008 approximately 215,020 new cases ...

High-normal phosphate levels linked to early atherosclerosis Misonix Reports First Quarter Fiscal Year 2009 Financial Results PharmacyChecker.com Publishes 'Safe Strategies for Drug Savings' to Help All Americans Get Affordable Medication CBA's Innovative Program for Managing Depression Earns National Recognition RecordGone.com Helps California Nurses Expunge Criminal Records to Meet More Stringent Licensing Standards Gender is key factor in determining overall survival of lung cancer patients

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Allergen, Occupational, Phthalic Anhydride Allergen, Occupational, Isocyanate TDI Allergen, Occupational, Ethylene Oxide Allergen, Mites, Euroglyphus maynei